Susan Berland
Direktor/Vorstandsmitglied bei Senti Sub I, Inc.
Vermögen: - $ am 31.05.2024
Profil
Susan D.
Berland is the founder of Veracyte, Inc. She is currently the Director at Senti Sub I, Inc. Formerly, she served as the Independent Director at Senti Biosciences, Inc. from 2021 to 2023.
Prior to that, she was the Chief Financial Officer at Poniard Pharmaceuticals, Inc. from 2004 to 2006.
She also worked as the Head-Financial Planning at Monsanto Co. from 1999 to 2000 and as the Chief Financial Officer at DNA Sciences, Inc. from 2000 to 2003.
Additionally, she held the position of Chief Financial Officer at Atreca, Inc. from 2016 to 2019 and at Mendel Biotechnology, Inc. from 2011 to 2014.
She briefly served as the Chief Financial Officer at ClearNote Health, Inc. in 2000.
In terms of education, Ms. Berland completed her undergraduate degree and obtained an MBA from the University of Wisconsin-Milwaukee.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
SENTI BIOSCIENCES, INC.
-.--% | 13.05.2024 | 0 ( -.--% ) | - $ | 31.05.2024 |
Aktive Positionen von Susan Berland
| Unternehmen | Position | Beginn |
|---|---|---|
Senti Sub I, Inc.
 Senti Sub I, Inc. BiotechnologyHealth Technology Senti Biosciences, Inc. develops novel therapeutics. It specializes in thetic biology, gene therapy and cell therapy. The company was founded by Timothy K. Lu, Wilson Wong, James J. Collins and Philip Lee in 2016 and is headquartered in South San Francisco, CA. | Direktor/Vorstandsmitglied | 01.06.2021 |
Ehemalige bekannte Positionen von Susan Berland
| Unternehmen | Position | Ende |
|---|---|---|
| SENTI BIOSCIENCES, INC. | Direktor/Vorstandsmitglied | 11.06.2023 |
| ATRECA, INC. | Finanzdirektor/CFO | 25.02.2019 |
Mendel Biotechnology, Inc.
 Mendel Biotechnology, Inc. Miscellaneous Commercial ServicesCommercial Services Mendel Biotechnology, Inc. operates as a plant biotechnology company. It develops genetic and chemical solutions for a range of agricultural markets. The firm offers biofuel feedstocks, yield enhancement, flowering, drought tolerance, freezing tolerance, disease resistance, nutrient use efficiency, and cold germination products. The company was founded in 1997 and is headquartered in Newark, CA. | Finanzdirektor/CFO | 01.12.2014 |
| PONIARD PHARMACEUTICALS, INC. | Finanzdirektor/CFO | 21.07.2006 |
DNA Sciences, Inc.
 DNA Sciences, Inc. Medical SpecialtiesHealth Technology Part of AbbVie, Inc., DNA Sciences, Inc. is a company that develops and produces in vitro diagnostic and research reagent products. The company is based in Fremont, CA. The company was founded by Hugh Young Rienhoff. DNA Sciences was acquired by Genaissance Pharmaceuticals, Inc., part of AbbVie, Inc. from October 07, 2005 on April 01, 2003 for $1.30 million. | Finanzdirektor/CFO | 01.05.2003 |
Ausbildung von Susan Berland
| University of Wisconsin-Milwaukee | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 4 |
|---|---|
| PONIARD PHARMACEUTICALS, INC. | Health Technology |
| VERACYTE, INC. | Health Technology |
| ATRECA, INC. | Health Technology |
| SENTI BIOSCIENCES, INC. | Health Technology |
| Private Unternehmen | 5 |
|---|---|
Monsanto Co.
 Monsanto Co. Wholesale DistributorsDistribution Services Monsanto Co. engages in the provision of agricultural products to farmers. It provides other seed companies with genetic material and biotechnology traits for their seed brands. The company was founded by John F. Queeny in 1901 and is headquartered in St. Louis, MO. | Distribution Services |
DNA Sciences, Inc.
DNA Sciences, Inc. Medical SpecialtiesHealth Technology Part of AbbVie, Inc., DNA Sciences, Inc. is a company that develops and produces in vitro diagnostic and research reagent products. The company is based in Fremont, CA. The company was founded by Hugh Young Rienhoff. DNA Sciences was acquired by Genaissance Pharmaceuticals, Inc., part of AbbVie, Inc. from October 07, 2005 on April 01, 2003 for $1.30 million. | Health Technology |
Mendel Biotechnology, Inc.
Mendel Biotechnology, Inc. Miscellaneous Commercial ServicesCommercial Services Mendel Biotechnology, Inc. operates as a plant biotechnology company. It develops genetic and chemical solutions for a range of agricultural markets. The firm offers biofuel feedstocks, yield enhancement, flowering, drought tolerance, freezing tolerance, disease resistance, nutrient use efficiency, and cold germination products. The company was founded in 1997 and is headquartered in Newark, CA. | Commercial Services |
Senti Sub I, Inc.
Senti Sub I, Inc. BiotechnologyHealth Technology Senti Biosciences, Inc. develops novel therapeutics. It specializes in thetic biology, gene therapy and cell therapy. The company was founded by Timothy K. Lu, Wilson Wong, James J. Collins and Philip Lee in 2016 and is headquartered in South San Francisco, CA. | Health Technology |
ClearNote Health, Inc.
 ClearNote Health, Inc. Pharmaceuticals: MajorHealth Technology ClearNote Health, Inc. is a company that develops liquid biopsy tests to detect cancers with high mortality rates early when they respond best to treatment. ClearNote Health is based in San Mateo, CA. The company uses its proprietary epigenomics platform to analyze individuals' changing biology that is yet to produce symptoms. The company was founded by Stephen D. Quake, and David Mullarkey has been the CEO of the company since 2022. | Health Technology |
